首页> 美国卫生研究院文献>Cancer Biotherapy Radiopharmaceuticals >Biological Effects of Irradiating Hepatocellular Carcinoma Cells by Internal Exposure with 125I-Labeled 5-Iodo-2′-Deoxyuridine-Chitosan Drug Loading Nanoparticles
【2h】

Biological Effects of Irradiating Hepatocellular Carcinoma Cells by Internal Exposure with 125I-Labeled 5-Iodo-2′-Deoxyuridine-Chitosan Drug Loading Nanoparticles

机译:内照射125I标记的5-碘-2-脱氧尿苷-壳聚糖载药纳米颗粒对肝癌细胞的生物学效应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, the authors evaluate the biological effects of irradiation of hepatocellular carcinoma cells by internal exposure with 125I-labeled 5-iodo-2′-deoxyuridine (125I-UdR)-chitosan drug loading nanoparticles (125I-UdR-CS-DLN). The authors observed that accumulation of nanoparticles was significantly (p<0.05) higher in hepatocellular carcinoma cells HepG2 than normal liver cells HL-7702 after treated with 125I-UdR-CS-DLN for 30 minutes. Survival of HepG2 cells was significantly lower at 125I-UdR-CS-DLN doses higher than 37 kBq/mL (more significant in the G1 phase and G2/M phase) than the HL-7702 cells. In addition, 125I-UdR-CS-DLN induced a higher level of DNA double-strand breaks than 125I-UdR, and HepG2 cells exhibited a lower level of DNA repair when compared with HL-7702 cells. In vivo animal experiments, TUNEL staining, after targeted treatment, showed that 125I-UdR-CS-DLN induced significant cell apoptosis in rabbit hepatocellular tumors in situ than 125I-UdR infusion at the same dose. In conclusion, hepatocellular carcinoma cells were significantly irradiated with 125I-UdR-CS-DLN compared with 125I-UdR, and 125I-UdR-CS-DLN irradiation enhanced DNA damage, induced liver cancer cell apoptosis, and prevented DNA damage repair. However, evaluating the extent of damage and organ sparing in vivo should also be considered.
机译:在这项研究中,作者评估了内部暴露于 125 I标记的5-iodo-2'-deoxyuridine( 125 I- UdR)-壳聚糖载药纳米粒子( 125 I-UdR-CS-DLN)。作者观察到,用 125 I-UdR-CS-DLN处理30分钟后,肝细胞癌细胞HepG2中的纳米颗粒积累明显高于正常肝细胞HL-7702(p <0.05)。与HL-7702细胞相比, 125 I-UdR-CS-DLN剂量高于37 kBq / mL时,HepG2细胞的存活率显着降低(在G1期和G2 / M期更显着)。此外, 125 I-UdR-CS-DLN诱导的DNA双链断裂水平高于 125 I-UdR,HepG2细胞的DNA水平较低与HL-7702细胞相比可修复。在体内动物实验中,靶向治疗后的TUNEL染色显示, 125 I-UdR-CS-DLN比 125 I-诱导原发性兔肝细胞瘤细胞凋亡明显。以相同剂量输注UdR。总之,与 125 I-UdR和 125 I-相比, 125 I-UdR-CS-DLN可以显着照射肝癌细胞。 UdR-CS-DLN辐射增强DNA损伤,诱导肝癌细胞凋亡,并阻止DNA损伤修复。但是,还应考虑评估体内的损伤程度和保留器官。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号